+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 2 Actively Recruiting clinical trials

O

Actively Recruiting

Researchers are studying acute intoxications in children to better understand how often these poisonings occur and what social and care factors contribute to them. This research focuses on children from 1 month to 16 years old who experience acute intoxication, aiming to improve future national diagnostic and treatment approaches. The study is a prospective, multicenter observational cohort conducted by AMIETOX at Poison Control Centres and paediatric emergency rooms. The study observes children who come to emergency rooms or contact Poison Control Centres due to acute intoxication, defined as exposure to harmful substances either by toxic nature or improper use. It does not involve specific treatments or interventions but records data over approximately one year to assess incidence and prevalence. This observational approach allows researchers to collect real-world information about poisoning cases in paediatric settings. Participants will be monitored through their visits or calls to study centers, with data collected on the nature and circumstances of the intoxications. Researchers will measure how often these poisonings occur and how widespread they are among children in the study. The study involves no active treatment or placebo, focusing instead on gathering information to inform better care strategies. Participation lasts about one year, during which safety and outcomes are tracked through standard care processes.

Age: 1Month - 16YearsAll Genders
31 locations
P

Actively Recruiting

Researchers are conducting the PERSEUS Registry to observe adults diagnosed with acute pulmonary embolism PE. This registry collects detailed information from initial emergency response, emergency department visits, hospital stay including the first 48 hours of treatment, and long-term follow-up up to five years. The study aims to understand routine care approaches and outcomes such as mortality, disease complications, and how existing risk assessment tools perform in real-world settings. The study includes two groups a retrospective cohort with patients diagnosed from January 2023 until local ethics approval, and a prospective cohort enrolling newly diagnosed patients for five years following approval. Data collected include pre-hospital emergency care, hospital diagnostics and treatments, hemodynamic and respiratory changes during the acute phase, hospital discharge outcomes, and long-term follow-up through various contact methods or medical record review. Participants receive routine care without changes from the study. Information such as vital signs, imaging, laboratory tests, and clinical events are recorded. Follow-up assessments track survival, recurrence, bleeding events, functional limitations, and development of chronic complications. Data privacy is maintained with pseudonymization, and quality checks are regularly performed. The study continues until 2032, with primary outcomes focusing on mortality at 30 days after diagnosis.

Age: 18Years +All Genders
16 locations